{"transactions":[{"id":2361158,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":129747,"kind":"person","name":"Madan Ajay","position":1,"cik":"0001807856","reported_name":"Madan Ajay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock (right to buy)","published_at":"2022-03-02T21:00:35.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":65400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option shall vest and become exercisable in a series of forty-eight (48) successive equal monthly installments measured from the vesting commencement date of February 28, 2022."}],"balance_after":65400,"derivative":{"exercise_price":20.02,"expiration_date":"2032-02-27","underlying":"Common Stock","underlying_shares":65400},"source":{"system":"sec-edgar","filing":"0001209191-22-015131","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1807856/000120919122015131/doc4.xml","form_type":"4"}},{"id":2361157,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":129747,"kind":"person","name":"Madan Ajay","position":1,"cik":"0001807856","reported_name":"Madan Ajay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2022-03-02T21:00:35.000Z","date":"2022-03-01","kind":"sale","acquired":true,"shares":9000,"price":19.88,"value":178920.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 30 days prior to the trading date."}],"balance_after":176995,"source":{"system":"sec-edgar","filing":"0001209191-22-015131","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1807856/000120919122015131/doc4.xml","form_type":"4"}},{"id":2361156,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":129747,"kind":"person","name":"Madan Ajay","position":1,"cik":"0001807856","reported_name":"Madan Ajay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2022-03-02T21:00:35.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":13950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 25% vesting annually beginning on March 15, 2023."}],"balance_after":185995,"source":{"system":"sec-edgar","filing":"0001209191-22-015131","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807856/000120919122015131/doc4.xml","form_type":"4"}},{"id":2406537,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":129747,"kind":"person","name":"Madan Ajay","position":1,"cik":"0001807856","reported_name":"Madan Ajay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2022-02-09T17:00:20.000Z","date":"2022-02-07","kind":"sale","acquired":false,"shares":13411,"price":17.8275,"value":239084.6025,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 30 days prior to the trading date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sales prices range between $17.170 and $18.015. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request."}],"balance_after":172045,"source":{"system":"sec-edgar","filing":"0001209191-22-008061","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807856/000120919122008061/doc4.xml","form_type":"4"}},{"id":2411801,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":129747,"kind":"person","name":"Madan Ajay","position":1,"cik":"0001807856","reported_name":"Madan Ajay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2022-02-04T16:26:08.000Z","date":"2021-11-19","kind":"other","acquired":true,"shares":785,"price":11.02,"value":8650.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares purchased under Crinetics Pharmaceuticals, Inc. 2018 Employee Stock Purchase Plan in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c)."}],"balance_after":185456,"source":{"system":"sec-edgar","filing":"0001209191-22-007198","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807856/000120919122007198/doc5.xml","form_type":"5"}},{"id":2530795,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":129747,"kind":"person","name":"Madan Ajay","position":1,"cik":"0001807856","reported_name":"Madan Ajay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-11-01T19:11:16.000Z","date":"2021-10-28","kind":"exercise","acquired":false,"shares":106383,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vested on July 17, 2017 and 1/48th of the total remaining number of shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":0.73,"expiration_date":"2028-03-16","underlying":"Common Stock","underlying_shares":106383},"source":{"system":"sec-edgar","filing":"0001209191-21-062263","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1807856/000120919121062263/doc4.xml","form_type":"4"}},{"id":2530794,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":129747,"kind":"person","name":"Madan Ajay","position":1,"cik":"0001807856","reported_name":"Madan Ajay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2021-11-01T19:11:16.000Z","date":"2021-10-28","kind":"exercise","acquired":true,"shares":106383,"price":0.73,"value":77659.59,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 772 shares acquired under the Issuer's Employee Stock Purchase Plan since the last Section 16 filing by the Reporting Person."}],"balance_after":184671,"source":{"system":"sec-edgar","filing":"0001209191-21-062263","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807856/000120919121062263/doc4.xml","form_type":"4"}},{"id":2820908,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":129747,"kind":"person","name":"Madan Ajay","position":1,"cik":"0001807856","reported_name":"Madan Ajay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-03-02T17:25:28.000Z","date":"2021-02-26","kind":"grant","acquired":true,"shares":131000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest and become exercisable in a series of forty-eight (48) successive equal monthly installments measured from the vesting commencement date of February 26, 2021."}],"balance_after":131000,"derivative":{"exercise_price":15.29,"expiration_date":"2031-02-25","underlying":"Common Stock","underlying_shares":131000},"source":{"system":"sec-edgar","filing":"0001209191-21-016278","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807856/000120919121016278/doc4.xml","form_type":"4"}},{"id":2876851,"issuer":{"id":3579,"kind":"organization","name":"Crinetics Pharmaceuticals, Inc."},"owners":[{"id":129747,"kind":"person","name":"Madan Ajay","position":1,"cik":"0001807856","reported_name":"Madan Ajay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2021-02-05T16:48:45.000Z","date":"2020-05-20","kind":"other","acquired":true,"shares":1470,"price":14.45,"value":21241.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares purchased under Crinetics Pharmaceuticals, Inc. 2018 Employee Stock Purchase Plan in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c),"}],"balance_after":77516,"source":{"system":"sec-edgar","filing":"0001209191-21-008120","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807856/000120919121008120/doc5.xml","form_type":"5"}}]}